StatPearls, LLC

  • Androgens
  • Hypogonadism
  • Libido
  • Testosterone

Androgen Replacement

Testosterone is FDA-approved as replacement therapy in men with low testosterone levels and those with symptoms of hypogonadism. Symptoms highly suggestive of hypogonadism include fewer or diminished spontaneous erections, decreased nocturnal penile tumescence, low libido, sparse beard growth, and shrinking testes. In males, the normal range for early morning testosterone is between 300 ng/dL to 1000 ng/dL but may vary from laboratory to laboratory. Clinicians must distinguish between primary (testicular) and secondary (pituitary-hypothalamic) hypogonadism. This review discusses the mechanism of action, adverse event profile, and other key factors (eg, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent to interprofessional team members who use exogenous testosterone to treat hypogonadism.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 2.5 creditsAAPA Category 1 Credit™Up to 2.5 creditsAMA PRA Category 1 Credit™Up to 2.5 creditsNursingUp to 2.5 creditsPharmacyUp to 2.5 credits

MOC types

ABS — Accredited CMEUp to 2.5 pointsABPATH — Lifelong LearningUp to 2.5 pointsABA — Lifelong LearningUp to 2.5 pointsABTS — Accredited CMEUp to 2.5 pointsABIM — Medical KnowledgeUp to 2.5 pointsABS — Self-AssessmentUp to 2.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 2.5 pointsABTS — Self-AssessmentUp to 2.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 8 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2.5 credits
  • MOC · Up to 2.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left